Abstract
This Health Industry Insights report provides guidance on life science IT
spending trends based on a detailed evaluation of survey results. This research
further evaluates how spending sentiment and behavior differ by various
industry subsegments based on company size (1,000 or more employees and fewer
than 1,000 employees), organization type (pharmaceutical, biotech, government,
academia/research hospital, and CRO/CMO), and functional area (basic research,
preclinical drug development, clinical trials, manufacturing/distribution, and
sales and marketing). Health Industry Insights' Leading Indicators in Life
Science
IT Spending Survey is a quarterly research effort that probes end-user opinions
throughout the life science value chain on planned IT spending, technology
adoption attitudes, perspectives on leading vendors, and other IT-related
topics. This data was gathered via a Web-based survey that yielded 154
participants, 63% of whom were manager level or above within their respective
organizations.
Eric Newmark, a research manager at Health Industry Insights, stated, "IT
spending growth has slowed a bit from last quarter, but still remains
relatively strong with 26% of the industry expecting to increase overall IT
spend in 2008. Decreased research and development productivity has caused the
industry to circulate ancillary spending back into innovation, which has helped
push research applications up in terms of investment priority. Companies are
now heavily focused on any activity that will help drive dollars toward
long-term pipeline development, so efforts such as IT outsourcing are beginning
to heat up."
| 
View Cart
